UA115232C2 - Препарат, що містить аморфний емодепсид - Google Patents

Препарат, що містить аморфний емодепсид

Info

Publication number
UA115232C2
UA115232C2 UAA201408095A UAA201408095A UA115232C2 UA 115232 C2 UA115232 C2 UA 115232C2 UA A201408095 A UAA201408095 A UA A201408095A UA A201408095 A UAA201408095 A UA A201408095A UA 115232 C2 UA115232 C2 UA 115232C2
Authority
UA
Ukraine
Prior art keywords
containing amorphous
preparations containing
emodepside
amorphous emodepside
preparations
Prior art date
Application number
UAA201408095A
Other languages
English (en)
Inventor
Венката-Рангарао Каніканті
Петра ЛАНГЕ
Ханс-Йюрген ХАМАНН
Петер Клайнебудде
Original Assignee
Байєр Інтеллектуал Проперті Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47358491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA115232(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Байєр Інтеллектуал Проперті Гмбх filed Critical Байєр Інтеллектуал Проперті Гмбх
Publication of UA115232C2 publication Critical patent/UA115232C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Винахід стосується препарату, що містить аморфний емодепсид в полівінілпіролідоновій матриці, фармацевтичного препарату, що містить такий препарат, та їх застосування проти ендопаразитів у тварин або людей.
UAA201408095A 2011-12-21 2012-12-18 Препарат, що містить аморфний емодепсид UA115232C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11194878 2011-12-21
PCT/EP2012/075909 WO2013092558A1 (de) 2011-12-21 2012-12-18 Zubereitungen enthaltend amorphes emodepsid

Publications (1)

Publication Number Publication Date
UA115232C2 true UA115232C2 (uk) 2017-10-10

Family

ID=47358491

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201408095A UA115232C2 (uk) 2011-12-21 2012-12-18 Препарат, що містить аморфний емодепсид

Country Status (24)

Country Link
US (3) US9539331B2 (uk)
EP (1) EP2793861B1 (uk)
JP (1) JP6185930B2 (uk)
KR (2) KR101979049B1 (uk)
CN (2) CN108187028A (uk)
AU (2) AU2012357848C1 (uk)
BR (1) BR112014014973A2 (uk)
CA (1) CA2859787C (uk)
CL (1) CL2014001637A1 (uk)
CO (1) CO6990713A2 (uk)
CR (1) CR20140293A (uk)
DO (1) DOP2014000140A (uk)
EC (1) ECSP14005917A (uk)
ES (1) ES2734352T3 (uk)
HK (1) HK1255536A1 (uk)
IL (1) IL233183B (uk)
MX (2) MX368209B (uk)
MY (1) MY175307A (uk)
NI (1) NI201400065A (uk)
PH (2) PH12014501438B1 (uk)
RU (2) RU2651761C2 (uk)
UA (1) UA115232C2 (uk)
WO (1) WO2013092558A1 (uk)
ZA (1) ZA201404529B (uk)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6185930B2 (ja) 2011-12-21 2017-08-23 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 非晶質エモデプシド含有製剤
JP7045191B2 (ja) 2015-05-20 2022-03-31 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP6943859B2 (ja) 2015-12-28 2021-10-06 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN115444927B (zh) * 2022-09-19 2023-06-02 山东第一医科大学附属肿瘤医院(山东省肿瘤防治研究院、山东省肿瘤医院) 艾默德斯在制备治疗三阴性乳腺癌的药物中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU669883B2 (en) 1992-03-17 1996-06-27 Astellas Pharma Inc. Depsipeptide derivative, production thereof and use thereof
DE19918325A1 (de) * 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10000792A1 (de) * 2000-01-11 2001-07-19 Bernhard C Lippold Formulierungen von Wirkstoffen in Form einer festen Dispersion
DE10031044A1 (de) 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
RU2315614C1 (ru) * 2006-04-19 2008-01-27 Бийтемир Ахмедович Султанбеков Средство "грепол" и способ применения его при паразитарных заболеваниях
NZ578259A (en) * 2007-02-09 2011-12-22 Pfizer Ltd Antiparasitic agents
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2010054833A1 (de) * 2008-11-14 2010-05-20 Ratiopharm Gmbh Intermediate und orale darreichungsformen enthaltend lenalidomid
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
JP6185930B2 (ja) 2011-12-21 2017-08-23 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 非晶質エモデプシド含有製剤

Also Published As

Publication number Publication date
ES2734352T3 (es) 2019-12-05
BR112014014973A2 (pt) 2017-06-13
AU2012357848C1 (en) 2018-07-19
IL233183B (en) 2020-01-30
RU2761529C2 (ru) 2021-12-09
RU2018105003A3 (uk) 2021-06-11
EP2793861B1 (de) 2019-05-01
US20140371139A1 (en) 2014-12-18
US9539331B2 (en) 2017-01-10
EP2793861A1 (de) 2014-10-29
US20180153957A1 (en) 2018-06-07
MX356094B (es) 2018-05-14
MY175307A (en) 2020-06-18
AU2012357848B2 (en) 2018-01-04
NI201400065A (es) 2015-12-10
AU2012357848A1 (en) 2014-07-10
PH12018500368A1 (en) 2018-07-23
WO2013092558A1 (de) 2013-06-27
CA2859787A1 (en) 2013-06-27
NZ625817A (en) 2016-08-26
MX2014007224A (es) 2014-09-22
CL2014001637A1 (es) 2014-11-21
ECSP14005917A (es) 2015-12-31
KR101979049B1 (ko) 2019-05-15
RU2014129620A (ru) 2016-02-10
JP2015502377A (ja) 2015-01-22
KR20140107296A (ko) 2014-09-04
KR101978620B1 (ko) 2019-08-28
CN108187028A (zh) 2018-06-22
US20170182118A1 (en) 2017-06-29
RU2651761C2 (ru) 2018-04-23
RU2018105003A (ru) 2019-02-22
ZA201404529B (en) 2017-06-28
KR20180084141A (ko) 2018-07-24
PH12014501438A1 (en) 2014-10-08
CN104023710A (zh) 2014-09-03
US10251932B2 (en) 2019-04-09
HK1255536A1 (zh) 2019-08-23
PH12014501438B1 (en) 2014-10-08
MX368209B (es) 2019-09-24
CA2859787C (en) 2020-09-08
AU2018202376B2 (en) 2019-06-20
CR20140293A (es) 2014-07-14
DOP2014000140A (es) 2014-07-31
IL233183A0 (en) 2014-07-31
CO6990713A2 (es) 2014-07-10
AU2018202376A1 (en) 2018-04-26
JP6185930B2 (ja) 2017-08-23

Similar Documents

Publication Publication Date Title
PH12018500368A1 (en) Preparations containing amorphous emodepside
HUP1100498A2 (en) Copper-resistant, fengycin hyperproducing bacillus mojavensis strain for protection against plant pests, its use and compounds containing the same
UA110103C2 (uk) Модифікований туберкульозний антиген
ZA201405436B (en) Herbicide tolerant cotton event pdab4468.19.10.3
IL233154A (en) Compounds, pharmaceuticals containing them and their uses
GB201106750D0 (en) Novel compounds
MX305105B (es) Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales.
EP2694834A4 (en) HAERGLATTUNGSFORMULIERUNGEN KERATINBASIS AND PROCESS THEREFOR AND SYSTEMS WITH IT
SI2739615T1 (sl) Fenil-3-aza-biciklo(3.1.0)heks-3-il-metanoni in njihova uporaba kot zdravilo
MX366090B (es) Combinación farmacéutica para usarse en mejorar la tolerancia a la glucosa en pacientes que padecen diabetes de tipo 2.
HK1211849A1 (en) Combination drug comprising gemigliptin and metformin, and method for the preparation thereof
EP2848122A4 (en) NEW PESTICIDES INCLUSION COMPOUNDS, COMPOSITIONS WITH SAID COMPLEXES AND USE THEREOF AS PESTICIDES
EP2899198A4 (en) SYNTHETIC PNTX (19) -EPEPTIDES, PHARMACEUTICAL COMPOSITIONS AND USES
HK1209027A1 (en) Vesicular formulations, uses and methods
MX346708B (es) Micobacteria recombinante como vacuna para uso en humanos.
HK1203061A1 (en) 1,3-diphenylpropane derivatives, preparations and uses thereof 13-
EP2789613A4 (en) 1,4-DIHYDRO-NAPHTHYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF AND ITS USE
EP2926811A4 (en) ARTEMISCULAR PHARMACEUTICAL COMPOSITION, MANUFACTURE AND USE
EP3048886A4 (en) 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use
淡漪 et al. All the things because I like
HUE039194T2 (hu) Szintetikus PNTX(19) peptid, gyógyszerészeti készítmények és alkalmazás
TH111755B (th) ไทรอะโซโลพิริดาซีนในรูปสารยับยั้ง par 1, การเตรียมของสารเหล่านั้นและการใช้สารเหล่านั้นเป็นยา